Latest news

Thumbnail image for A&E pressures not down to GP access, study finds

A&E pressures not down to GP access, study finds

The rising tide of accident and emergency attendances is being driven by long-term health conditions rather than a lack of GP provision, concludes a study by Queen Mary University of London.

16th January 2018

Thumbnail image for SMC bars four medicines from NHS

SMC bars four medicines from NHS

The Scottish Medicines Consortium has rejected NHS funding for four new therapies, including Bristol-Myers Squibb and Roche’s respective cancer medicines Opdivo and Gazyvaro.

16th January 2018

Thumbnail image for US expands scope of BI’s lung cancer drug Gilotrif

US expands scope of BI’s lung cancer drug Gilotrif

US regulators have approved a supplemental New Drug Application for Boehringer Ingelheim’s lung cancer drug Gilotrif for first-line treatment of patients with metastatic non-small cell lung cancer whose tumours have non-resistant epidermal growth factor receptor.

16th January 2018

Thumbnail image for NHS chooses next batch of entrepreneurs for support

NHS chooses next batch of entrepreneurs for support

The NHS has now chosen 138 clinical entrepreneurs to design and deliver new technological solutions and innovations in healthcare, including the appointment of five healthcare scientists working on addressing conditions such as sickle cell disease and allergic reactions.

12th January 2018

Thumbnail image for Emergency care in England “in a state of emergency”

Emergency care in England “in a state of emergency”

Emergency care is now in a state of emergency as missed targets reach an all-time high, bed occupancy rates surge, and flu cases increase sharply, and health chiefs warn that patients are “dying in corridors” and the system is “on its knees”.

12th January 2018

Thumbnail image for EU clears Roche’s Ocrevus for MS

EU clears Roche’s Ocrevus for MS

Roche’s Ocrevus has been approved for use in Europe to treat adults with relapsing multiple sclerosis (RMS) and early primary progressive multiple sclerosis (PPMS).

12th January 2018

Thumbnail image for Heptares, ICL sign gastrointestinal R&D pact

Heptares, ICL sign gastrointestinal R&D pact

Heptares Therapeutics, the UK-headquartered wholly-owned subsidiary of Japan’s Sosei Group, has formed a new drug research and development pact with Imperial College London focused on gastrointestinal disease.

11th January 2018

Thumbnail image for NHS Confed orders reports into NHS funding needs

NHS Confed orders reports into NHS funding needs

The NHS Confederation has tasked the Institute for Fiscal Studies and the Health Foundation with analysing the funding needs of the UK’s health and care systems over the next 15 years.

11th January 2018

Previous  --   1 2 3 4 5 6 7 8 9 10   --  Next

Download our apps

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Download